Nea Management Company, LLC Mersana Therapeutics, Inc. Transaction History

Nea Management Company, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $100 Million - $164 Million	-5,959,520 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$16.2 - $25.7 $32.4 Million - $51.4 Million	-2,000,000 Reduced 25.13%	5,959,520 $111 Million
Q2 2020 Aug 05, 2020	SELL	$5.24 - $23.4 $21 Million - $93.7 Million	-4,004,129 Reduced 33.47%	7,959,520 $186 Million
Q3 2019 Oct 11, 2019	BUY	$1.54 - $4.2 $106,848 - $291,404	69,382 Added 0.58%	11,963,649 $18.9 Million
Q1 2019 May 08, 2019	BUY	$3.51 - $7.3 $13.2 Million - $27.4 Million	3,750,000 Added 46.04%	11,894,267 $62.6 Million
Q3 2017 Nov 03, 2017	BUY	$14.8 - $18.06 $121 Million - $147 Million	8,144,267	8,144,267 $141 Million

136

101M

77.2K

453K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $43.7M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Nea Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Nea Management Company, LLC with notifications on news.